SRT is primarily indicated for preterm infants born before 34 weeks of gestation, as their lungs are often underdeveloped and lack sufficient natural surfactant. However, it can also be used in full-term infants with surfactant deficiency due to conditions like meconium aspiration syndrome, neonatal pneumonia, or persistent pulmonary hypertension of the newborn.
